Document is current
Any future updates will be listed below
-
Authors
Dronkers, Wouter J. https://orcid.org/0000-0001-7684-1787
Geelen, Femke
Gross, Alyson
van den Berg, René
Coutinho, Jonathan M.
Regli, Luca
Vandertop, W. Peter
Verbaan, Dagmar
Germans, Menno R.
-
Funding
Funding for this research was provided by:
Koninklijke Nederlandse Akademie van Wetenschappen
- License Information
-
More Information
Article History
Received: 13 May 2026
Revised: 7 June 2026
Accepted: 9 June 2026
First Online: 25 June 2026
Declarations
:
: JC received financial support from the Dutch Heart Foundation, Medtronic, Bayer and Boehringer (all fees were paid to his employer), and is co-founder and shareholder of TrianecT. RvdB reports a consultancy agreement with Cerenovus (Johnson & Johnson).
: Institutional Board Approval was granted from the Medical Ethics Committee of the AUMC (W22_107) and from the Ethics Committee of the USZ (BASEC nr. 2022-00732), separately, prior to the recruitment of eligible patients. This study was completed in accordance with the Helsinki Declaration as revised in 2013. Informed consent was requested and granted from all included participants.
